A team led by University of Toronto researchers developed the signature as a clinical assay that could predict treatment response.
The team is making several improvements to its MyGene2 platform portal in an attempt to encourage open sharing of genomic data.
Alere said its would-be acquirer has no grounds for seeking termination, but Abbott cited adverse material events as a basis for ending the deal.
Most recently, Celgene has licensed the GNS platform for internal use and made an undisclosed equity investment in the company.
The company's PrenaTest BioIT analysis software is now also cleared for use with a new methylation-specific qPCR assay for the detection of fetal trisomy 21.
The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.
Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.
In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.
Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.